REVERSIBLE INHIBITION OF OSTEOCLASTIC ACTIVITY BY BONE-BOUND GALLIUM(III)

被引:39
作者
BLAIR, HC
TEITELBAUM, SL
TAN, HL
SCHLESINGER, PH
机构
[1] JEWISH HOSP ST LOUIS,DEPT PATHOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,MED CTR,DEPT PHYSIOL & CELL BIOL,ST LOUIS,MO 63110
关键词
BONE RESORPTION; OSTEOCLAST; GALLIUM; HYPERCALCEMIA; OSTEOPOROSIS;
D O I
10.1002/jcb.240480409
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gallium(III) is a new therapeutic agent for hypercalcemia. Ga3+ reduces osteoclast action, but how it inhibits the cell's physiology is unknown. In vivo, 7-12-mu-M Ga(III) reduces calcium release from bone, but surprisingly, 10-100-mu-M Ga3+ added to isolated avian osteoclasts did not reduce their degradation of L-(5-H-3)-proline bone. H-3-proline labels bone collagen specifically, and collagenolysis is an excellent indicator of bone dissolution because collagen is the least soluble component of bone. Ga(III) > 100-mu-M inhibited osteoclasts in vitro, but also killed the cells. To resolve this apparent conflict, we measured Ga-67 distribution between bone, cells, and media. Gallium binds avidly but slowly to bone fragments. One hundred micrograms of bone clears 60% of 1-mu-M gallium from 500-mu-l of tissue culture medium, with steady state at > 24 h. Osteoclasts on bone inhibited gallium binding capacity approximately 40%, indicating a difference in available binding area and suggesting that osteoclasts protect their substrate from Ga binding. Less gallium binds to bone in serum-containing medium than in phosphate-buffered saline; 30% reduction of the affinity constant suggests that the serum containing medium competes with bone binding. Consequently, the effect of [Ga] on bone degradation was studied using accurately controlled amounts of Ga(III) pre-bound to the bone. Under these conditions, gallium sensitivity of osteoclasts is striking. At 2 days, 100-mu-g of bone pre-incubated with 1 ml of 1-mu-M Ga3+, with 10 pmoles Ga3+/mu-g bone, was degraded at 50% the rate of control bone; over 50 pM Ga3+/mu-g bone, resorption was essentially zero. In contrast, pre-treatment of bone with [Ga3+] as high as 15-mu-M had no significant effect on bone resorption rate beyond 3 days, indicating that gallium below approximately 150 pg/mu-g bone acts for a limited time and does not permanently damage the cells. We conclude that bone-bound Ga(III) from medium concentrations < 15-mu-M inhibits osteoclasts reversibly, while irreversible toxicity occurs at solution [Ga3+] > 50-mu-M.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 15 条
  • [11] MUGGIA FM, 1990, SEMIN ONCOL, V17, P3
  • [12] NEUMAN WF, 1958, CHEMICAL DYNAMICS BO, P55
  • [13] STREWLER GJ, 1990, ANNU REV MED, V41, P35
  • [14] RODENT PERITONEAL-MACROPHAGES AS BONE RESORBING CELLS
    TEITELBAUM, SL
    STEWART, CC
    KAHN, AJ
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1979, 27 (03) : 255 - 261
  • [15] GALLIUM NITRATE INHIBITS CALCIUM RESORPTION FROM BONE AND IS EFFECTIVE TREATMENT FOR CANCER-RELATED HYPERCALCEMIA
    WARRELL, RP
    BOCKMAN, RS
    COONLEY, CJ
    ISAACS, M
    STASZEWSKI, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (05) : 1487 - 1490